Insmed (INSM) Inventory Average (2019 - 2026)
Insmed (INSM) recorded quarterly Inventory Average of $132.5 million in Q1 2026, up 4.72% quarter-over-quarter from $126.5 million in Q4 2025, and up 32.96% on a YoY basis from $99.6 million in Q1 2025.
Insmed (INSM) Inventory Average (2019 - 2026) Analysis & Trends
Insmed's Inventory Average history runs 8 years deep, the most recent figure standing at $132.5 million for Q1 2026.
- In Q1 2026, Inventory Average rose 32.96% year-over-year to $132.5 million; the TTM figure through Mar 2026 stood at $132.5 million (up 32.96% YoY), while the FY2025 annual figure was $115.3 million, up 26.85% from the prior year.
- Inventory Average was $132.5 million for Q1 2026 at Insmed, up from $126.5 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $132.5 million in Q1 2026 to a low of $65.6 million in Q1 2022.
- Historically, Inventory Average has averaged $88.7 million across 5 years, with a median of $83.1 million in 2024.
- The sharpest annual moves came in 2022 and 2026: Inventory Average rose 1.29% in 2022, then surged 32.96% in 2026.
- A 5-year view of Inventory Average shows it stood at $68.1 million in 2022, then grew by 18.34% to $80.6 million in 2023, then gained by 22.26% to $98.5 million in 2024, then grew by 28.41% to $126.5 million in 2025, then gained by 4.72% to $132.5 million in 2026.
- The last three Inventory Average figures came in at $132.5 million (Q1 2026), $126.5 million (Q4 2025), and $114.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn | 132.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 132.49 Mn |
| Dec 31, 2025 | 126.52 Mn |
| Sep 30, 2025 | 114.29 Mn |
| Jun 30, 2025 | 104.16 Mn |
| Mar 31, 2025 | 99.65 Mn |
| Dec 31, 2024 | 98.52 Mn |
| Sep 30, 2024 | 94.27 Mn |
| Jun 30, 2024 | 86.51 Mn |
| Mar 31, 2024 | 83.10 Mn |
| Dec 31, 2023 | 80.59 Mn |
| Sep 30, 2023 | 77.64 Mn |
| Jun 30, 2023 | 74.33 Mn |
| Mar 31, 2023 | 70.62 Mn |
| Dec 31, 2022 | 68.10 Mn |
| Sep 30, 2022 | 66.65 Mn |
| Jun 30, 2022 | 65.58 Mn |
| Mar 31, 2022 | 65.58 Mn |
| Dec 31, 2021 | 67.23 Mn |
| Sep 30, 2021 | 63.92 Mn |
| Jun 30, 2021 | 56.22 Mn |